This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Oct;38(10):485-8.

doi: 10.1016/s0300-2896(02)75270-8.

[Dyspnea and quality of life in chronic obstructive pulmonary disease]

[Article in Spanish]

C Sanjuás¹

Affiliations

PMID: 12372199
DOI: 10.1016/s0300-2896(02)75270-8

Review

[Dyspnea and quality of life in chronic obstructive pulmonary disease]

[Article in Spanish]

C Sanjuás. Arch Bronconeumol. 2002 Oct.

. 2002 Oct;38(10):485-8.

doi: 10.1016/s0300-2896(02)75270-8.

Author

C Sanjuás¹

Affiliation

¹ Servei de Pneumologia. Hospital del Mar. Barcelona. Spain. Csanjuas@imas.imim.es

PMID: 12372199
DOI: 10.1016/s0300-2896(02)75270-8

No abstract available

PubMed Disclaimer

Similar articles

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Brusasco V, et al. Thorax. 2003 May;58(5):399-404. doi: 10.1136/thorax.58.5.399. Thorax. 2003. PMID: 12728159 Free PMC article. Clinical Trial.
[Cost-effectiveness analysis of tiotropium compared to ipratropium and salmeterol].
García Ruiz AJ, Leiva Fernández F, Martos Crespo F. García Ruiz AJ, et al. Arch Bronconeumol. 2005 May;41(5):242-8. doi: 10.1016/s1579-2129(06)60217-6. Arch Bronconeumol. 2005. PMID: 15919004 Spanish.
Tiotropium for chronic obstructive pulmonary disease.
[No authors listed] [No authors listed] Drug Ther Bull. 2003 Feb;41(2):15-6. doi: 10.1136/dtb.2003.41215. Drug Ther Bull. 2003. PMID: 12630336 Review.
Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
Tennant RC, Erin EM, Barnes PJ, Hansel TT. Tennant RC, et al. Curr Opin Pharmacol. 2003 Jun;3(3):270-6. doi: 10.1016/s1471-4892(03)00047-x. Curr Opin Pharmacol. 2003. PMID: 12810191 Review.
Tiotropium versus salmeterol in COPD.
Lloret-Linares C, Bergmann JF. Lloret-Linares C, et al. N Engl J Med. 2011 Jun 30;364(26):2552-3; author reply 2553-4. doi: 10.1056/NEJMc1104617. N Engl J Med. 2011. PMID: 21714656 No abstract available.

See all similar articles

Cited by

Determinants and predictors of the cost of COPD in primary care: a Spanish perspective.
de Miguel Diez J, Carrasco Garrido P, García Carballo M, Gil de Miguel A, Rejas Gutierrez J, Bellón Cano JM, Hernández Barrera V, Jimenez García R. de Miguel Diez J, et al. Int J Chron Obstruct Pulmon Dis. 2008;3(4):701-12. doi: 10.2147/copd.s2427. Int J Chron Obstruct Pulmon Dis. 2008. PMID: 19281084 Free PMC article.
Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.
Valero C, Monteagudo M, Llagostera M, Bayona X, Granollers S, Acedo M, Ferro JJ, Rodríguez-Latre L, Almeda J, Muñoz L; COPD Group of SAP Baix LLobregat Centre. Valero C, et al. BMC Public Health. 2009 Dec 1;9:442. doi: 10.1186/1471-2458-9-442. BMC Public Health. 2009. PMID: 20128887 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ediciones Doyma, S.L.
- Elsevier Science
Medical
- MedlinePlus Health Information